NFKB1 and atherosclerosis: miR-155 and miR-146a are also involved in the regulation of the NF-κB signaling pathway; for example, miR-155, which is positively regulated by TNF-α in HUVEC, suppresses the NF-κB signaling pathway in atherosclerosis by targeting transcription factor p65 and decreasing monocyte adhesion to the endothelium (35).